UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Overexpression of GPR40 in Pancreatic β-Cells Augments Glucose-Stimulated Insulin Secretion and Improves Glucose Tolerance in Normal and Diabetic Mice

Diabetes (New York, N.Y.), 2009-05, Vol.58 (5), p.1067-1076

2009

Volltextzugriff (PDF)

Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob/ob mice

European journal of pharmacology, 2008-07, Vol.588 (2), p.325-332

2008

Volltextzugriff (PDF)

Activation of Human Peroxisome Proliferator-Activated Receptor (PPAR) Subtypes by Pioglitazone

Biochemical and biophysical research communications, 2000-11, Vol.278 (3), p.704-711

2000

Volltextzugriff (PDF)

Novel 5-Substituted-1H-tetrazole Derivatives as Potent Glucose and Lipid Lowering Agents

Chemical and Pharmaceutical Bulletin, 2002, Vol.50(1), pp.100-111

2002

Volltextzugriff (PDF)

Anti-obesity effects of a mixture of thiamin, arginine, caffeine, and citric acid in non-insulin dependent diabetic KK mice

Journal of Nutritional Science and Vitaminology, 2003, Vol.49(1), pp.56-63

2003

Volltextzugriff (PDF)

The dipeptidyl peptidase-4 inhibitor alogliptin in combination with pioglitazone improves glycemic control, lipid profiles, and increases pancreatic insulin content in ob/ob mice

European journal of pharmacology, 2009-01, Vol.602 (2), p.448-454

2009

Volltextzugriff (PDF)

Studies on Non-Thiazolidinedione Antidiabetic Agents. 3. Preparation and Biological Activity of the Metabolites of TAK-559

Chemical and Pharmaceutical Bulletin, 2004, Vol.52(1), pp.120-124

2004

Volltextzugriff (PDF)

Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes

Diabetes (New York, N.Y.), 1999-04, Vol.48 (4), p.927-932

1999

Volltextzugriff (PDF)

Novel 5-Substituted 2,4-Thiazolidinedione and 2,4-Oxazolidinedione Derivatives as Insulin Sensitizers with Antidiabetic Activities

Journal of medicinal chemistry, 2002-03, Vol.45 (7), p.1518-1534

2002

Volltextzugriff (PDF)

Dietary Fat Elevates Hepatic ApoA-I Production by Increasing the Fraction of Apolipoprotein A-I mRNA in the Translating Pool (∗)

The Journal of biological chemistry, 1995-08, Vol.270 (34), p.19833-19838

1995

Volltextzugriff (PDF)

A novel dipeptidyl peptidase-4 inhibitor, alogliptin (SYR-322), is effective in diabetic rats with sulfonylurea-induced secondary failure

Life sciences (1973), 2009-07, Vol.85 (3), p.122-126

2009

Volltextzugriff (PDF)

Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin

Diabetes (New York, N.Y.), 1999-09, Vol.48 (9), p.1822-1829

1999

Volltextzugriff (PDF)

Effects of Dietary Fructose or Glucose on Triglyceride Production and Lipogenic Enzyme Activities in the Liver of Wistar Fatty Rats, an Animal Model of NIDDM

Endocrine Journal, 1997, Vol.44(2), pp.239-245

1997

Volltextzugriff (PDF)

alpha-Glucosidase inhibitor, its structure and mechanism of antidiabetic action

Nihon rinshō, 2002-09, Vol.60 Suppl 9, p.393

Odaka, Hiroyuki

2002

Volltextzugriff (PDF)

Overexpression of GPR40 in Pancreatic [beta]-Cells Augments Glucose-Stimulated Insulin Secretion and Improves Glucose Tolerance in Normal and Diabetic Mice

Diabetes (New York, N.Y.), 2009-05, Vol.58 (5), p.1067

2009

Volltextzugriff (PDF)

A novel oxyiminoalkanoic acid derivative, TAK-559, activates human peroxisome proliferator-activated receptor subtypes

European journal of pharmacology, 2004-07, Vol.495 (1), p.17-26

2004

Volltextzugriff (PDF)

Allylthiamindisulfide and related compounds enhance thermogenesis with increasing noradrenaline and adrenaline secretion in rats

Journal of Nutritional Science and Vitaminology, 1999, Vol.45(5), pp.643-653

1999

Volltextzugriff (PDF)

Antiobesity and antidiabetic actions of a new potent disaccharidase inhibitor in genetically obese-diabetic mice, KKAy

Journal of Nutritional Science and Vitaminology, 1992, Vol.38(1), pp.27-37

1992

Volltextzugriff (PDF)

Hypertension and insulin resistance in obese type 2 diabetic Wistar fatty rat

Nihon rinshō, 2003-07, Vol.61 (7), p.1119

2003

Volltextzugriff (PDF)

Marked reduction of pancreatic insulin content in male ventromedial hypothalamic-lesioned spontaneously non-insulin-dependent diabetic (Goto-Kakizaki) rats

Metabolism, clinical and experimental, 1994, Vol.43 (1), p.32-37

1994

Volltextzugriff (PDF)

Animal models of diabetes and development of anti-diabetic agents

Folia Pharmacologica Japonica, 2006, Vol.128(1), pp.37-41

2006

Volltextzugriff (PDF)

Increased adipose expression of the uncoupling protein-3 gene by thiazolidinediones in Wistar fatty rats and in cultured adipocytes

Diabetes (New York, N.Y.), 1998-11, Vol.47 (11), p.1809-1814

1998

Volltextzugriff (PDF)

Inhibition of progressive reduction of islet β-cell mass in spontaneously diabetic Goto-Kakizaki rats by α-glucosidase inhibitor

Metabolism, clinical and experimental, 2000-03, Vol.49 (3), p.347-352

2000

Volltextzugriff (PDF)

ApoA-I knockout mice: characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes

Journal of lipid research, 1997-05, Vol.38 (5), p.1033-1047

1997

Volltextzugriff (PDF)

Changes in glycated haemoglobin levels in diabetic rats measured with an automatic affinity HPLC

Clinical and experimental pharmacology & physiology, 2003-10, Vol.30 (10), p.752-758

2003

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(108)

Publikationsform

Sprache

Englisch
(109)
Japanisch
(63)

Erscheinungsjahr

n.n

Thema

Science & Technology
(69)
Life Sciences & Biomedicine
(59)
Animals
(53)
Male
(33)
Rats
(33)
Biological And Medical Sciences
(32)
Medical Sciences
(26)
Humans
(19)
Mice
(18)
Rats, Wistar
(16)
Endocrinology & Metabolism
(12)
Female
(12)
Pharmacology & Pharmacy
(12)
Pharmacology. Drug Treatments
(12)
Diabetes
(11)
Diabetes. Impaired Glucose Tolerance
(10)
Endocrine Pancreas. Apud Cells
(10)
Endocrinopathies
(10)
Hypoglycemic Agents - Pharmacology
(10)
Obesity
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Overexpression of GPR40 in Pancreatic β-Cells Augments Glucose-Stimulated Insulin Secretion and Improves Glucose Tolerance in Normal and Diabetic Mice

Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob/ob mice

Activation of Human Peroxisome Proliferator-Activated Receptor (PPAR) Subtypes by Pioglitazone

Novel 5-Substituted-1H-tetrazole Derivatives as Potent Glucose and Lipid Lowering Agents

Anti-obesity effects of a mixture of thiamin, arginine, caffeine, and citric acid in non-insulin dependent diabetic KK mice

The dipeptidyl peptidase-4 inhibitor alogliptin in combination with pioglitazone improves glycemic control, lipid profiles, and increases pancreatic insulin content in ob/ob mice

Studies on Non-Thiazolidinedione Antidiabetic Agents. 3. Preparation and Biological Activity of the Metabolites of TAK-559

Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes

Novel 5-Substituted 2,4-Thiazolidinedione and 2,4-Oxazolidinedione Derivatives as Insulin Sensitizers with Antidiabetic Activities

Dietary Fat Elevates Hepatic ApoA-I Production by Increasing the Fraction of Apolipoprotein A-I mRNA in the Translating Pool (∗)

A novel dipeptidyl peptidase-4 inhibitor, alogliptin (SYR-322), is effective in diabetic rats with sulfonylurea-induced secondary failure

Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin

Effects of Dietary Fructose or Glucose on Triglyceride Production and Lipogenic Enzyme Activities in the Liver of Wistar Fatty Rats, an Animal Model of NIDDM

alpha-Glucosidase inhibitor, its structure and mechanism of antidiabetic action

Overexpression of GPR40 in Pancreatic [beta]-Cells Augments Glucose-Stimulated Insulin Secretion and Improves Glucose Tolerance in Normal and Diabetic Mice

A novel oxyiminoalkanoic acid derivative, TAK-559, activates human peroxisome proliferator-activated receptor subtypes

Allylthiamindisulfide and related compounds enhance thermogenesis with increasing noradrenaline and adrenaline secretion in rats

Antiobesity and antidiabetic actions of a new potent disaccharidase inhibitor in genetically obese-diabetic mice, KKAy

Hypertension and insulin resistance in obese type 2 diabetic Wistar fatty rat

Marked reduction of pancreatic insulin content in male ventromedial hypothalamic-lesioned spontaneously non-insulin-dependent diabetic (Goto-Kakizaki) rats

Animal models of diabetes and development of anti-diabetic agents

Increased adipose expression of the uncoupling protein-3 gene by thiazolidinediones in Wistar fatty rats and in cultured adipocytes

Inhibition of progressive reduction of islet β-cell mass in spontaneously diabetic Goto-Kakizaki rats by α-glucosidase inhibitor

ApoA-I knockout mice: characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes

Changes in glycated haemoglobin levels in diabetic rats measured with an automatic affinity HPLC

Suchergebnisse filtern